Introduction to Alunbrig (Brigatinib) 180mg
Alunbrig (Brigatinib) 180mg is a prescription medicine used in the treatment of certain lung cancers, particularly ALK-positive non-small cell lung cancer (NSCLC). This medicine belongs to a specialized group of targeted anticancer drugs that work by blocking abnormal cancer growth signals and helping slow disease progression.
Alunbrig (Brigatinib) 180mg is classified under Prescription Medicines, Oncology Medicines, Targeted Cancer Therapies, and Oral Anticancer Drugs. It contains Brigatinib, which works by inhibiting abnormal ALK-related signaling pathways involved in cancer cell growth and survival.
In some markets, Biganib 180mg is available as a local brand containing the same active ingredient Brigatinib, offering a similar therapeutic effect when prescribed by a qualified healthcare professional.
What Is Alunbrig (Brigatinib)?
Alunbrig is the original brand name for Brigatinib, an oral targeted therapy widely used for the treatment of ALK-positive non-small cell lung cancer.
Brigatinib belongs to a class of medicines known as Tyrosine Kinase Inhibitors (TKIs). These medicines help block specific abnormal proteins that promote cancer cell growth.
Local brands such as Biganib 180mg contain the same active compound and may be used depending on physician recommendation and regional availability.
Drug Class and Mechanism of Action
Brigatinib is classified as a targeted tyrosine kinase inhibitor with strong anti-ALK activity.
How Brigatinib Works
It works in several ways:
- Blocks abnormal ALK signaling in cancer cells
- Helps slow cancer cell growth and spread
- Supports targeted destruction of cancer-related pathways
Through these mechanisms, Brigatinib helps control disease progression in selected lung cancer patients.
How Alunbrig Works in the Body
Some lung cancers grow because of abnormal ALK gene changes that drive cancer cell division. Alunbrig helps block these signals and reduces the ability of cancer cells to survive and multiply.
Key Actions of Brigatinib
- Targeting ALK-positive cancer cells
- Slowing tumor growth and spread
- Supporting long-term targeted cancer control
Some local brands such as Biganib deliver the same active compound, allowing similar targeted cancer treatment when prescribed appropriately.
Medical Uses of Alunbrig (Brigatinib) 180mg
Alunbrig (Brigatinib) 180mg is commonly prescribed for certain ALK-positive lung cancers.
Alunbrig for ALK-Positive Non-Small Cell Lung Cancer
For patients with ALK-positive non-small cell lung cancer, Alunbrig may be prescribed as part of targeted therapy to help control disease progression.
Potential Benefits
- Targeted treatment for ALK-positive NSCLC
- Slower cancer progression
- Oral treatment convenience in selected patients
Local brands like Biganib 180mg may also be used under medical supervision when Brigatinib therapy is recommended.
Alunbrig for Advanced Lung Cancer Management
Alunbrig is also used in selected patients with advanced or metastatic ALK-positive lung cancer based on physician evaluation and treatment planning.
Treatment Benefits
- Better disease control in targeted patients
- Support for long-term oncology management
- Improved precision treatment approach
Who Can Take Biganib 180mg?
Because Brigatinib is a potent anticancer medicine, treatment should always be supervised by an experienced healthcare provider.
Eligibility Criteria
Patients may be prescribed Alunbrig if they:
- Have ALK-positive non-small cell lung cancer confirmed by appropriate testing
- Need oral targeted cancer therapy
- Can undergo regular medical and laboratory monitoring
Certain local brands such as Biganib may also be considered depending on availability and physician decision.
Who Should Avoid Alunbrig (Brigatinib) 180mg
Alunbrig should NOT be used by:
- Individuals with hypersensitivity to Brigatinib
- Patients advised against its use due to severe treatment-related risk factors
- Individuals who cannot undergo appropriate cancer treatment monitoring
Alunbrig (Brigatinib) 180mg Dosage and Administration
Standard Dosage Guidelines
Typical dosage recommendations include:
- Alunbrig 180mg as directed by the physician
- Usually taken orally once daily
- Can be taken with or without food
- Dose escalation and maintenance schedule should follow oncology guidance
Dosage Adjustments
Doctors may adjust the dose depending on:
- Treatment tolerability
- Lung, liver, or blood pressure-related side effects
- Overall treatment response
Side Effects of Alunbrig 180mg
Like all targeted cancer medicines, Alunbrig may cause side effects.
Common Side Effects
- Nausea
- Diarrhea
- Fatigue
- Cough
Serious Side Effects
- Lung Problems: Shortness of breath, cough, or severe respiratory symptoms
- High Blood Pressure: May require monitoring and treatment
- Liver Problems: Elevated liver enzymes or liver-related symptoms
Patients should report any unusual symptoms to their doctor immediately.
Storage:
Store below 25°C in a cool, dry place, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Frequently Asked Questions (FAQs)
1. What is Alunbrig (Brigatinib) 180mg used for?
Alunbrig (Brigatinib) 180mg is used to treat ALK-positive non-small cell lung cancer.
2. Is Alunbrig 180mg chemotherapy?
No. Brigatinib is a targeted cancer therapy, not traditional chemotherapy.
3. Can Alunbrig (Brigatinib) 180mg be taken with food?
Yes. It can generally be taken with or without food unless your doctor advises otherwise.
4. Can Biganib 180mg cause breathing problems?
Yes. Brigatinib may cause serious lung-related side effects in some patients and requires close monitoring.
5. Can pregnant women take Biganib 180mg?
Brigatinib should be used during pregnancy only if specifically recommended by a qualified healthcare professional.
6. Is Biganib 180mg the same as Alunbrig?
Biganib 180mg contains Brigatinib, the same active ingredient found in Alunbrig. Local or generic versions may be available depending on market authorization and physician recommendation.
7. Do I need a prescription to buy Biganib (Brigatinib) 180mg?
Yes. Biganib 180mg is a prescription-only medicine and should only be used under the supervision of a qualified healthcare professional.
Medical Disclaimer
Disclaimer:
The information provided on this page is for educational and informational purposes only and should not be considered medical advice. Alunbrig (Brigatinib) 180mg is a prescription-only medication and must be used strictly under the supervision of a qualified healthcare professional. Always consult your physician before starting, stopping, or changing any medication.
